Follow
Joseph Jankovic
Joseph Jankovic
Professor of Neurology, Distinguished Chair in Movement Disorders, Director of Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine
No verified email - Homepage
Title
Cited by
Cited by
Year
Parkinson¢s disease: clinical features and diagnosis
J Jankovic
Journal of neurology, neurosurgery & psychiatry 79 (4), 368-376, 2008
68882008
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
62142008
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) report of the NINDS-SPSP international workshop
I Litvan, Y Agid, D Calne, G Campbell, B Dubois, RC Duvoisin, CG Goetz, ...
Neurology 47 (1), 1-9, 1996
27701996
Phenomenology and classification of dystonia: a consensus update
A Albanese, K Bhatia, SB Bressman, MR DeLong, S Fahn, VSC Fung, ...
Movement disorders 28 (7), 863-873, 2013
23072013
Levodopa and the progression of Parkinson's disease
Parkinson Study Group
New England Journal of Medicine 351 (24), 2498-2508, 2004
22562004
Unified Huntington's disease rating scale: reliability and consistency
K Kieburtz, JB Penney, P Como, N Ranen, A Feigin, D Abwender, ...
Movement disorders 11 (2), 136-142, 1996
19761996
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
J Jankovic, M McDermott, J Carter, S Gauthier, C Goetz, L Golbe, S Huber, ...
Neurology 40 (10), 1529-1529, 1990
15561990
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
14962019
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan
CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ...
Movement disorders 22 (1), 41-47, 2007
14942007
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
14752011
Therapeutic uses of botulinum toxin
J Jankovic, MF Brin
New England Journal of Medicine 324 (17), 1186-1194, 1991
11291991
A double-blind, delayed-start trial of rasagiline in Parkinson's disease
CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ...
New England Journal of Medicine 361 (13), 1268-1278, 2009
10402009
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt, KJ Burchiel, CL Comella, J Jankovic, AE Lang, ER Laws Jr, ...
Neurology 60 (1), 69-73, 2003
9002003
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ...
Movement disorders 32 (9), 1264-1310, 2017
8422017
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the …
GT Stebbins, CG Goetz, DJ Burn, J Jankovic, TK Khoo, BC Tilley
Movement Disorders 28 (5), 668-670, 2013
7562013
Tourette's syndrome
J Jankovic
New England Journal of Medicine 345 (16), 1184-1192, 2001
732*2001
DJ-1 and á-synuclein in human cerebrospinal fluid as biomarkers of Parkinson¢s disease
Z Hong, M Shi, KA Chung, JF Quinn, ER Peskind, D Galasko, J Jankovic, ...
Brain 133 (3), 713-726, 2010
7232010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
WJ Marks, RT Bartus, J Siffert, CS Davis, A Lozano, N Boulis, J Vitek, ...
The Lancet Neurology 9 (12), 1164-1172, 2010
7102010
Parkinson's disease and movement disorders
J Jankovic, E Tolosa
Lippincott Williams & Wilkins, 2007
6832007
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
RG Holloway, I Shoulson, S Fahn, K Kieburtz, A Lang, K Marek, ...
Archives of neurology 61 (7), 1044-1053, 2004
6752004
The system can't perform the operation now. Try again later.
Articles 1–20